ESC TV Today – Your Cardiovascular News

Konstantinos Koskinas, cardiologist and news summarizer; Michiel Rienstra, academic AF guideline coordinator; Arian Sultan, interventional electrophysiologist specialized in ablation techniques; Jason Andrade, electrophysiologist expert in AF monitoring. They discuss AF burden and how to measure it. They explore pulsed field ablation: benefits, limits and wider uses. They cover post-ablation drug and anticoagulation strategies.

Thomas F. Luescher, cardiology expert and long-time clinician, explores AI, big data and the future of guidelines. He discusses datasets from imaging, wearables, genomics and registries. He covers continuous updates versus safety, validation and portability of prediction models, and the data skills clinicians will need. Practical ideas on streamlining guideline content and avoiding clinician alert fatigue are highlighted.

Michael Papadakis, a sports cardiology expert on hypertrophic cardiomyopathy, and Kostas Koskinas, an interventional cardiologist who summarizes recent studies. They discuss AI and big data shaping guideline development and living, continuously updated recommendations. They cover individualized risk scores, EHR integration, and new, personalized advice on exercise for people with hypertrophic cardiomyopathy.

Annemien van den Bosch, adult congenital heart disease specialist at Erasmus MC, discusses atrial septal defect imaging and management. She covers multimodality imaging choices. She outlines when surgery or device closure is preferred. She highlights lifelong specialised follow-up, pregnancy counselling, paradoxical embolism indications, and emerging bioresorbable and minimally invasive approaches.

Rasha Al-Lamee, interventional cardiologist researching angina and PCI. Roxana Mehran, expert in coronary revascularization. Annemien van den Bosch, adult congenital cardiologist focusing on atrial septal defects. JP Carpenter, cardiology commentator with study highlights. They discuss atrial septal defect diagnosis and closure strategies. They debate conservative versus invasive care for chronic coronary syndromes and review recent cardiovascular study headlines.

Borge Nordestgaard, a clinician-researcher from Copenhagen University Hospital known for his work on lipoprotein(a), discusses prevalence and strong genetic control of Lp(a). He explains Lp(a) biology, evidence linking it to calcific aortic valve stenosis, screening recommendations, current management strategies, and an ongoing trial testing major Lp(a) lowering to slow valve progression.

Hugh Montgomery, intensive care medicine chair focused on climate and health. JP Carpenter, cardiology commentator who summarizes recent studies. Borge Nordestgaard, cardiology professor known for Lp(a) research. They discuss Lp(a) links to aortic valve stenosis and emerging RNA therapies. They cover climate change’s immediate threats to cardiovascular health and practical mitigation and adaptation steps clinicians can take.

Fleur Tjong, a cardiology expert at Amsterdam UMC specializing in digital cardiology and AI in electrophysiology, engages in a rich discussion about the future of heart health. She explores how AI can predict atrial fibrillation risks using ECG data and emphasizes personalized approaches to monitoring. Fleur also highlights the importance of integrating wearable data into electronic health records without overwhelming clinics. Additionally, she discusses training for clinicians in digital tools, the health economics of remote monitoring, and her vision for AI's role in arrhythmia care over the next five years.

Join interventional cardiologist Davide Capodanno, who reviews the latest TAVI evidence, including durability and risks for younger patients. Cardiac electrophysiologist Fleur Tjong discusses the role of wearables and AI in ECGs, highlighting how these tools can refine device therapy decisions. Cardiology commentator JP Carpenter provides summaries of recent cardiovascular studies, addressing the implications for statins and exercise. The panel also explores intriguing links between gratitude and heart health.

In this engaging discussion, Steffen Massberg, a leading cardiologist from Ludwig Maximilians University Hospital, dives into dual antiplatelet therapy (DAPT). He highlights how about 40% of patients meet high bleeding risk criteria and discusses the implications for shortening DAPT duration. Massberg reviews evidence from key trials supporting shorter therapies and emphasizes the importance of individualized strategies. He also addresses barriers like physician fears regarding stent thrombosis while advocating for advanced imaging techniques to enhance decision-making in DAPT.